Eli Lilly Director Ralph Alvarez Receives 10.495-Share Award

What Happened
Ralph Alvarez, a director of Eli Lilly & Co (LLY), was awarded 10.495 shares (stock units) on 2026-08-17 at a reported per-share value of $1,183.16, for a total value of $12,417. This was an award/deferral of director compensation (code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-08-17; Form 4 filed: 2026-08-18 (timely filing).
• Amount: 10.495 shares (stock units) @ $1,183.16 each; total reported value $12,417.
• Shares owned after transaction: Not specified in the filing.
• Footnote: Alvarez elected to defer these shares as stock units under the Lilly Directors' Deferral Plan; the units will be settled in common stock when he separates from service.
• Footnote: The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest.

Context
This is a routine director compensation deferral (award) rather than a buy or sell that signals a trading decision. Deferred stock units are common for directors who elect to take pay in equity and will convert to actual shares upon separation, and do not necessarily reflect immediate ownership/control of the shares.